Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-18

Clinical Trial Update: Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

View source ↗

Summary

The study explored how the vitreomacular interface affects progression of diabetic macular edema following anti-VEGF injections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • anti-VEGF therapy

Snippet

Sponsor: Fundació Institut Germans Trias i Pujol | Conditions: Diabetic Macular Edema, Vitreomacular Interface | Status: COMPLETED